USPTO serial 99274084
ACTUAL REGENERATIVE SURGERY INTERNATIONAL ACADEMY ARSIA
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- OROSS, JILLIAN E
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with ACTUAL REGENERATIVE SURGERY INTERNATIONAL ACADEMY ARSIA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,246*
Plus Government fees of $600
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Jersey City, NJ, US
Jersey City, NJ, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lindsay Heather Kaplan
Lindsay Heather Kaplan TOPSHELF TRADEMARKS LLC8 North Front StreetSuite 2002Kingston, NY 12401Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Conducting, arranging and organizing trade shows and trade fairs for commercial and advertising purposes; Organizing and conducting job fairs; Organizing, promoting and conducting exhibitions, tradeshows and events for business purposes; Business management consulting, strategic planning and business advisory services provided to regenerative medicine professionals; Organizing business networking events in the field of regenerative medicine, cellular therapies, and isolating, treating and injecting blood platelets or cells into patients; Consulting services in the field of medical practice management for others in the field of regenerative medicine, cellular therapies, and isolating, treating and injecting blood platelets or cells into patients | ACTIVE | — |
| 041 | Conducting workshops and seminars in regenerative medicine and isolating, treating and injecting blood platelets or cells into patients; Arranging and conducting of training courses in the field of regenerative medicine and isolating, treating and injecting blood platelets or cells into patients; Development and dissemination of printed educational materials of others in the field of regenerative medicine and isolating, treating and injecting blood platelets or cells into patients; Conducting distance learning instruction in the field of regenerative medicine and isolating, treating and injecting blood platelets or cells into patients; Providing education in the field of regenerative medicine and isolating, treating and injecting blood platelets or cells into patients rendered through video conference; Educational services, namely, conducting classes, seminars, workshops, trainings, lectures in the fields of regenerative medicine and isolating, treating and injecting blood platelets or cells into patients and distribution of training materials in connection therewith; Educational services, namely, providing academic performance evaluation, guidance, and monitoring for regenerative medicine professionals; Educational services, namely, providing online instruction in the field of regenerative medicine, cellular therapies and isolating, treating and injecting blood platelets or cells into patients; Arranging and conducting of colloquia in the field of regenerative medicine, cellular therapies, and isolating, treating and injecting blood platelets or cells into patients; Arranging and conducting of conventions in the field of regenerative medicine, cellular therapies, and isolating, treating and injecting blood platelets or cells into patients; Educational services, namely, developing, arranging, and conducting educational conferences and programs and providing courses of instruction in the field of regenerative medicine, cellular therapies, and isolating, treating and injecting blood platelets or cells into patients; Education services, namely, providing non-downloadable webinars in the field of regenerative medicine, cellular therapies, and isolating, treating and injecting blood platelets or cells into patients; Instruction in the field of regenerative medicine and cellular therapy, namely seminars and conferences in the field of regenerative medicine and cellular therapy | ACTIVE | — |
| 042 | Providing information about medical and scientific research via a website; Research and development in the field of voluntary ethical and scientific standards in medicine, regenerative medicine, cellular therapy, and isolating, treating and injecting blood platelets or cells into patients; Scientific research in the field of regenerative medicine, cellular therapy and isolating, treating and injecting blood platelets or cells into patients; Laboratory research in the field of regenerative medicine, cellular therapy and isolating, treating and injecting blood platelets or cells into patients; Medical and scientific research, namely, conducting clinical trials for others | ACTIVE | — |
| 044 | Consulting services in the field of medical care; Providing medical information, consultancy and advisory services; Clinical medical practice consultation services; Providing medical information in the field of regenerative medicine and isolating, treating and injecting blood platelets or cells into patients; Clinical medical consultation services; Medical services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Regen Lab USA, LLC
- Other trademarks owned by Regen Lab USA, LLC
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ACTUAL REGENERATIVE SURGERY INTERNATIONAL ACADEMY ARSIA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 20, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 19, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 19, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 19, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 24, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 30, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 30, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 24, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 5, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 4, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 4, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 4, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 2, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 2, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 2, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 26, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 15, 2025 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Nov 14, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 9, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 9, 2025 | NWAP | NEW APPLICATION ENTERED | — |